Key Activities and Accomplishments
ART Services: CDC has helped strengthen the scope and quality of antiretroviral treatment (ART) services for adults and children. As of FY 2017, CDC has (32,119) PLHIV on treatment (PEPFAR Annual Progress Report, 2017). CDC also significantly contributes to the adoption of the “test and start” approach and new national HIV management guidelines.
Prevention of Mother-to-Child Transmission (PMTCT): CDC experts contributed to eMTCT plan, option B+ pilot and scale-up phases, all resulting in increased availability of option B+ Services in DRC. In FY 2017, CDC had (1,555) pregnant women on ART (PEPFAR Annual Progress Report, 2017).
Orphan and Vulnerable Children (OVC): CDC aims to keep children safe, healthy, stable and schooled. Through CDC support, in FY 2017 8,092 OVC received services to improve their well-being.
TB/HIV Integration: CDC helps in the development of Tuberculosis infection control national plan, promotes Isoniazid Preventive Therapy (IPT) and supports TB case identification (including through Xpert). Under CDC support 970 TB/HIV patients co-infected received ART (PEPFAR Annual Progress Report, 2017).
Viral load (VL): CDC increased capacity and access for EID and VL testing. In FY 2017, PEPFAR supported laboratories processed 19,807 samples (61.83% coverage) for VL.
Key populations: FY 2017, resulted in over 14,000 Female Sex Workers (FSW) and Men who have Sex with Men (MSM) tested for HIV, resulting in 568 positives. Of these positive, 511 were initiated on ART. The remaining HIV negative clients were supported to stay negative.